MDA Advocacy Institute: ALS Policy Updates

Dr. Amelie Gubitz of the National Institutes of Health (NIH)'s National Institute of Neurological Disorders and Stroke (NINDS) covered the NIH's role in ACT for ALS implementation. MDA’s EVP, Public Policy and Advocacy, Paul Melmeyer, and Director, Access Policy, Joel Cartner provided the latest insights and news on the ALS policy landscape, including FDA's role in implementing ACT for ALS and the ALS Better Care Act.